The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. - Wikidata - wikimedia - TriplyDB

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q34529904

about

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function Effect of amphetamines on blood pressure A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges Using stimulants to treat ADHD-related emotional lability Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications Psychopharmacology of Tic Disorders Functional consequences of attention-deficit hyperactivity disorder on children and their families.Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Lisdexamfetamine dimesylate: the first prodrug stimulant.A multidimensional approach to medication selection in the treatment of children and adolescents with ADHD.The dopamine dilemma: using stimulants and antipsychotics concurrently.Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.Partnership in the Treatment of Childhood Mental Health Problems: A Pediatric Perspective.Misplaced Fear? FDA Contraindication to Psychostimulant Use in Children with Tics Helping Children Hospitalized for Rages.Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficit/hyperactivity disorder.Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Inattention, but not OCD, predicts the core features of hoarding disorder.Attention-deficit/hyperactivity disorder and telemental health An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol

P2860

Q22241421-5FDAB3B6-0AB6-4D66-B047-638D36D4BF60 Q22252308-95114DEE-6282-47AE-9872-810DCF30B795 Q24240569-C2A9F773-A0EE-4D1E-B4C5-6AB834FA229C Q24632726-6E401923-00BD-47B3-99B9-B914B388491E Q26765320-45C58883-2F73-40AC-820D-A0C38B3D29F7 Q27002372-CBE1C54F-49F5-44C5-8747-7A78044AB13C Q27687469-2BCE9591-936F-437A-8CF9-9A20A7E32582 Q28068166-D9D896E5-5DFC-456F-9635-EAB8DEA6438A Q28238719-85497D79-9987-4599-9DAC-F378FC49C8FD Q28239619-A3D694E5-8392-4BD0-BFF7-45427589F5FC Q28282770-F3E18B21-F07D-4893-A759-1ED92104D7EE Q28284641-88F904B3-41D2-400D-B090-2C8F87FC07C4 Q28287983-922AF0D4-63A7-4191-B57A-0AA7A1BFFF46 Q28295134-6745B143-DBA4-4D57-B8DA-E3A066B17366 Q28972388-30352FB7-B839-4C6D-8897-6DF4D59E06BA Q30251626-B813E4E6-ED62-4998-9389-A97B86784C56 Q33694959-11B65BA3-A2C2-4903-BF27-80E443FECFE5 Q33782844-B01AC16D-229B-4C8B-A9FF-96E4CADFC373 Q33782856-E36D6A75-A685-4CE7-A93C-FF12A75AF8EB Q33819917-4984C8DE-CBE3-407F-A34B-1208FE3EA01A Q33865315-EB3E77A1-31E1-4CF9-B3B9-AB805B0EC13D Q33870580-5AADF6F8-732D-4830-B2E9-01E0D8B8EC4F Q33894687-8C96C940-1944-4C05-955C-4D98E28268ED Q33900149-E2F13E83-9FB8-4E23-ACA8-6F6A637462DB Q33969132-28455E0F-E658-4FCB-9BDF-D4780029786F Q34032634-D75594BA-4B5F-4119-8D99-0EEEBF51F755 Q34041636-5E293A01-D491-4CE8-89CE-DE81D139A82F Q34075088-A727CCBB-2A65-4060-8A9A-138F80F4FEE9 Q34111063-4C209156-0DA7-475F-BCA2-665877416A58 Q34112093-14FA3B45-0CDE-49FC-835F-F5E3DDF90685 Q34131298-69AD0A3A-8C67-4700-8D5C-6FCC5B7FD6D0 Q34205490-7B24F8AA-E8B1-41B8-AD4B-B8A3DB4D4B78 Q34232286-88557355-AAE1-48B9-94FC-93E8FC12ED55 Q34286130-C54EEE64-414D-4096-93E7-034727EA78C4 Q34498667-A5EE89A5-65ED-48CC-94CF-BA119C7F3AAF Q34518522-B8501CAA-B068-42AF-8499-4BFD24BF9F13 Q34572185-9E78577B-B036-4149-BD8B-2E1CC0DDC91D Q34582405-067EC28D-493E-4591-8ED8-D61888DE2A4C Q34603303-F6EC1EF2-FD57-4D79-BDA2-0D87FE927B5B Q34647061-D0EF1DBD-86DE-498A-A30D-714437280FE0

P2860

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q34529904

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@ast

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@en

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@nl

type

label

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@ast

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@en

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@nl

prefLabel

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@ast

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@en

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@nl

P1433

Q34529904-4F854C97-DF9B-416A-95AF-0723250E4ED2

P1476

Q34529904-B9653F80-CC73-48A3-AF43-2B66A0EE4B2D

P2093

Q34529904-13F8DD5C-AB1C-4666-8437-049714049F7C

Q34529904-39AFE508-34B0-4467-8A29-ECE383F0637E

Q34529904-61CBAA1B-ED66-4B3A-946E-634D4B04637A

Q34529904-7AD95781-74A7-46D1-88CA-0DCB10A13C14

Q34529904-85A558CE-5904-4037-BCDD-6F668698851A

Q34529904-D13AE250-5B94-4524-B6B5-51CCD214266C

Q34529904-E98E5B89-D540-476B-994F-39D13229097C

Q34529904-F8A813EF-B7F7-40EE-88A2-CEE2D750920C

Q34529904-F90BA2CA-8461-4A36-9ED4-CAC4C1A6DD36

P304

Q34529904-8702B223-D570-4D96-9B31-1108211A163A

P31

Q34529904-2167044C-34D8-4925-88F0-CDDBB0A52B6D

P356

Q34529904-1CA329E1-CDF2-4029-92C1-0EF6D5ED273D

P433

Q34529904-406C67A6-D5C2-4E65-9A8C-D0F60293EED0

P478

Q34529904-0254FB2E-DD24-4279-9DDB-7A7B7E1F9964

P50

Q34529904-0EC2CD78-3FFA-4F31-AECB-A8BC962928B0

P577

Q34529904-5EB03B64-91FF-49D0-B7E6-A0BC5667830D

P5875

Q34529904-257EFA08-C1EE-427D-8D28-AF5F74E37D05

P698

Q34529904-63A32AD2-B760-4F3C-B1F9-E8926CF8C9D9

P921

Q34529904-0557040A-B526-4AB2-9A89-6F9DB11DFE42

Q34529904-6AA97EA1-5AF0-408A-960B-D8F52F9A7600

Q34529904-A2D699CF-47F7-40B6-8FF1-6FCE579FC4DE

P356

01.CHI.0000215326.51175.EB

P1433

Journal of the American Academy of Child and Adolescent Psychiatry

P1476

The Texas Children's Medicatio ...... eficit/hyperactivity disorder.

@en

P2093

C Keith Corners

http://www.w3.org/2001/XMLSchema#string

Carroll W Hughes

http://www.w3.org/2001/XMLSchema#string

Graham J Emslie

http://www.w3.org/2001/XMLSchema#string

James M Swanson

http://www.w3.org/2001/XMLSchema#string

James T McCracken

http://www.w3.org/2001/XMLSchema#string

M Lynn Crismon

http://www.w3.org/2001/XMLSchema#string

Molly Lopez

http://www.w3.org/2001/XMLSchema#string

Steven R Pliszka

http://www.w3.org/2001/XMLSchema#string

Texas Consensus Conference Pan ...... Deficit Hyperactivity Disorder

http://www.w3.org/2001/XMLSchema#string

P304

642-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.CHI.0000215326.51175.EB

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Peter S. Jensen

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7061999

http://www.w3.org/2001/XMLSchema#string

P698

16721314

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

pharmacotherapy